Meta-analysis of 6 RCTs (277 participants) with acute hamstring injury: platelet-rich plasma vs control shortened return-to-play (21.4 vs 30.0 days; P=0.045) with high heterogeneity; reinjury (15% vs 16%) and adverse events did not differ. Low to moderate certainty.
Meta-analysisn = 277
Nakagawa et al. Effects of percutaneous platelet-rich plasma injection on return-to-play after acute hamstring muscle injury: a systematic review and meta-analysis